Harm potential: GREEN—PPIs remain appropriate first-line therapy; this STOP recommends co-administration of probiotics, not PPI avoidance.
Evidence map3 cited passagesInspect provenance +
Promote gastric Candida colonization—96.9% detection rate; Candida significantly increases with both short and long-term PPI
Leave esophageal dysbiosis untreated—PPI does NOT change esophageal or oropharyngeal microbial composition despite reducing inflammatory markers
In children: PPI + probiotics → 6.2% dysbiosis vs. PPI + placebo → 56.2% dysbiosis. In adults: probiotics + PPI significantly restored Bifidobacterium (6.3→9.2 lgCFU/g), reduced CRP (P=0.0486), and reduced adverse reactions from 16.6% to 6.6%.
Contents
1. When This STOP Does NOT Apply2. When This STOP Applies3. The Treatment Paradox4. The Evidence for Co-Administration5. Alternative ApproachWhen This STOP Does NOT Apply#
Short-term PPI use (<4 weeks) for acute GERD exacerbation—microbiome impact is minimal at short durations. PPI therapy already combined with probiotic co-administration. Barrett's esophagus or erosive esophagitis where PPI is mandatory regardless of microbiome effects.
When This STOP Applies#
Long-term PPI monotherapy (>8 weeks) without any microbiome support. Patients on PPI with emerging signs of dysbiosis (recurrent C. difficile, SIBO symptoms, oral/gastric candidiasis). Persistent GERD symptoms despite PPI therapy (54.1% of long-term users).
The Treatment Paradox#
PPIs improve esophageal inflammation (IL-6 ↓38%, IL-8 ↓41%, NF-kB ↓29%) but simultaneously:
- Worsen gut bacterial dysbiosis—increase Enterobacteriaceae, Staphylococcaceae; deplete Bifidobacteriaceae, Ruminococcaceae, Lachnospiraceae
- Promote gastric Candida colonization—96.9% detection rate; Candida significantly increases with both short and long-term PPI[1]Shi 2023 — PPI-Induced Fungal Dysbiosis in Patients with Gastroesophageal Reflux DiseaseYichao Shi, Jianfeng Li, Shuntian Cai et al. · 2023Open reference 1 ↓
- Leave esophageal dysbiosis untreated—PPI does NOT change esophageal or oropharyngeal microbial composition despite reducing inflammatory markers[2]Park 2020 — NERD Treatment and Esophageal MicrobiomePark · 2020Open reference 2 ↓
- Create infection risk—increased C. difficile, Campylobacter, Shigella, Salmonella; SIBO
The Evidence for Co-Administration#
In children: PPI + probiotics → 6.2% dysbiosis vs. PPI + placebo → 56.2% dysbiosis. In adults: probiotics + PPI significantly restored Bifidobacterium (6.3→9.2 lgCFU/g), reduced CRP (P=0.0486), and reduced adverse reactions from 16.6% to 6.6%.[3]Yin 2025 — Probiotics Combined with PPI for GERD: Randomized Controlled TrialYin · 2025Open reference 3 ↓
Alternative Approach#
- Always co-administer probiotics with PPI therapy
- Dietary adjuncts: Mediterranean diet, low-carbohydrate diet, soluble fiber
- Minimize PPI duration and dose—step-down to H2RA or on-demand dosing
- For mild GERD: evaluate dietary-only approaches before PPI initiation
References 4
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Yichao Shi, Jianfeng Li, Shuntian Cai et al. (2023). Shi 2023 — PPI-Induced Fungal Dysbiosis in Patients with Gastroesophageal Reflux Disease. Frontiers in Cellular and Infection Microbiology.
- 2
Park (2020). Park 2020 — NERD Treatment and Esophageal Microbiome. Scientific Reports.
- 3
Yin (2025). Yin 2025 — Probiotics Combined with PPI for GERD: Randomized Controlled Trial. Pharmacy Practice.
- 4
Deshpande NP, Riordan SM, Castano-Rodriguez N et al. (2018). Deshpande 2018 — Esophageal Microbiome Signatures and Host Genetics. Microbiome.
Article network
Mentioned here 2
Pages linking here 1
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +1 −1
Inspect exact Git diff ↗ - published revision
maintenance: 409 source fixes, 34 entity updates, 17 concept updates, 30 analysis outputs
WikiBiome Deploy Bot · +1 −1
Inspect exact Git diff ↗ - published revision
semantic integrity pass: boundary fixes, 10 interventions, 31 STOPs, 2 supersessions, keystone revalidation
WikiBiome Deploy Bot · +30 −0
Inspect exact Git diff ↗ - published revision
Deepen metal/concept entities + 8 new sources for T1D/schizophrenia
WikiBiome Deploy Bot · +3 −3
Inspect exact Git diff ↗ - published revision
Deep content + citation pass: 10 entities enriched, 7 new sources, DOI integrity
WikiBiome Deploy Bot · +0 −41
Inspect exact Git diff ↗ - published revision
Adversarial audit fixes: confidence downgrades, disclaimers, STOP safety, entity cleanup
WikiBiome Deploy Bot · +14 −0
Inspect exact Git diff ↗ - published revision
Tier 1 new condition signatures: schizophrenia, ovarian cancer, CKD, GERD
WikiBiome Deploy Bot · +41 −0
Inspect exact Git diff ↗ - published revision
Tier 1 new condition signatures: schizophrenia, ovarian cancer, CKD, GERD
WikiBiome Deploy Bot · +41 −0
Inspect exact Git diff ↗